HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Seiji Okada Selected Research

Cytokines

12/2023The IL-17-IL-17RA axis is required to promote osteosarcoma progression in mice.
1/2023Cepharanthine inhibits dengue virus production and cytokine secretion.
1/2022Zinc chelator treatment in crush syndrome model mice attenuates ischemia-reperfusion-induced muscle injury due to suppressing of neutrophil infiltration.
1/2022Epidural Fat Tissue Is More Effective for Scar Prevention Than Conventional Subcutaneous Fat Grafting After Laminectomy in a Mouse Model.
12/2021Homophilic Interaction of CD147 Promotes IL-6-Mediated Cholangiocarcinoma Invasion via the NF-κB-Dependent Pathway.
1/2021Inflammation-driven senescence-associated secretory phenotype in cancer-associated fibroblasts enhances peritoneal dissemination.
2/2019Attenuation of CD47-SIRPα Signal in Cholangiocarcinoma Potentiates Tumor-Associated Macrophage-Mediated Phagocytosis and Suppresses Intrahepatic Metastasis.
2/2016Proliferation of functional human natural killer cells with anti-HIV-1 activity in NOD/SCID/Jak3(null) mice.
8/2014Current status of treatment for primary effusion lymphoma.
4/2012Age-related differences in cellular and molecular profiles of inflammatory responses after spinal cord injury.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Seiji Okada Research Topics

Disease

87Neoplasms (Cancer)
05/2024 - 09/2002
32Cholangiocarcinoma
07/2023 - 06/2010
30Infections
10/2023 - 09/2009
28Spinal Cord Injuries (Spinal Cord Injury)
01/2023 - 01/2004
20Primary Effusion Lymphoma
10/2022 - 09/2009
14Rheumatoid Arthritis
01/2024 - 12/2018
13Neoplasm Metastasis (Metastasis)
12/2023 - 04/2012
11Inflammation (Inflammations)
03/2024 - 07/2002
10Lymphoma (Lymphomas)
03/2023 - 09/2009
10Acquired Immunodeficiency Syndrome (AIDS)
10/2016 - 04/2005
9Congenital Abnormalities (Deformity)
02/2024 - 10/2021
9Carcinogenesis
12/2023 - 05/2007
8Pain (Aches)
03/2024 - 04/2012
8Wounds and Injuries (Trauma)
10/2023 - 04/2008
8Cicatrix (Scar)
01/2023 - 12/2005
7Osteoporosis
02/2024 - 10/2021
6Gliosis
01/2023 - 06/2005
5Melanoma (Melanoma, Malignant)
01/2018 - 08/2013
5Ascites
06/2017 - 09/2009
4Sarcoma (Soft Tissue Sarcoma)
03/2024 - 01/2017
4Spinal Cord Diseases
12/2023 - 04/2012
4Hypoxia (Hypoxemia)
01/2023 - 01/2016
4Fibrosis (Cirrhosis)
01/2023 - 01/2017
4Leukemia
03/2021 - 08/2007
4Hematologic Neoplasms (Hematological Malignancy)
01/2016 - 03/2012
3Multiple Myeloma
03/2024 - 05/2022
3Postmenopausal Osteoporosis
01/2024 - 10/2021
3Osteoarthritis
01/2024 - 01/2022
3Hematoma
01/2024 - 03/2013
3Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2024 - 03/2010
3Hallux Valgus
08/2023 - 10/2021
3Hyperglycemia
07/2023 - 10/2014
3Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated)
04/2023 - 11/2007
3Graft vs Host Disease (Graft-Versus-Host Disease)
01/2023 - 01/2016
3Necrosis
01/2023 - 03/2007
3Squamous Cell Carcinoma of Head and Neck
12/2022 - 02/2015
3BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
01/2022 - 01/2013
3Breast Neoplasms (Breast Cancer)
01/2021 - 09/2014
3Neurodegenerative Diseases (Neurodegenerative Disease)
10/2020 - 01/2012
3HIV Infections (HIV Infection)
09/2018 - 09/2016
3Disease Progression
01/2018 - 04/2005
3Lung Neoplasms (Lung Cancer)
01/2017 - 01/2014
2Spinal Injuries (Spinal Injury)
03/2024 - 01/2023

Drug/Important Bio-Agent (IBA)

18Proteins (Proteins, Gene)FDA Link
11/2023 - 10/2002
15CytokinesIBA
12/2023 - 07/2002
8Therapeutic UsesIBA
01/2024 - 08/2007
7DNA (Deoxyribonucleic Acid)IBA
03/2024 - 03/2004
7Transcription Factors (Transcription Factor)IBA
01/2023 - 01/2011
5Reactive Oxygen Species (Oxygen Radicals)IBA
04/2023 - 07/2012
5cepharanthineIBA
01/2023 - 09/2009
5CollagenIBA
01/2023 - 11/2011
5Interleukin-6 (Interleukin 6)IBA
01/2022 - 06/2005
5Antineoplastic Agents (Antineoplastics)IBA
05/2019 - 08/2013
5Liposomes (Liposome)IBA
12/2017 - 03/2010
5NF-kappa B (NF-kB)IBA
01/2014 - 11/2007
4CyclodextrinsIBA
11/2023 - 10/2014
4Folic Acid (Vitamin M)FDA LinkGeneric
11/2023 - 03/2014
4Messenger RNA (mRNA)IBA
01/2023 - 07/2012
4Small Interfering RNA (siRNA)IBA
11/2020 - 07/2012
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
07/2016 - 03/2013
4src-Family KinasesIBA
03/2012 - 04/2005
3C-Reactive ProteinIBA
03/2024 - 05/2022
3Biomarkers (Surrogate Marker)IBA
03/2024 - 03/2019
3romosozumabIBA
01/2024 - 10/2021
3AntigensIBA
01/2024 - 01/2018
3Peptides (Polypeptides)IBA
11/2023 - 01/2018
3Janus Kinase InhibitorsIBA
07/2023 - 01/2022
3Indicators and Reagents (Reagents)IBA
04/2023 - 08/2015
3VaccinesIBA
01/2023 - 09/2002
3ZincIBA
01/2023 - 03/2019
3Interleukin-6 Receptors (Interleukin 6 Receptor)IBA
01/2023 - 06/2005
3PeriostinIBA
01/2023 - 03/2017
3Cadherins (E-Cadherin)IBA
01/2023 - 01/2014
3IntegrinsIBA
01/2023 - 07/2017
3RNA (Ribonucleic Acid)IBA
01/2023 - 01/2013
3Monoclonal AntibodiesIBA
10/2022 - 06/2021
3BerberineIBA
10/2022 - 04/2012
3GemcitabineFDA Link
01/2022 - 01/2021
3AcidsIBA
07/2021 - 03/2020
3Histones (Histone)IBA
01/2021 - 01/2017
3Nuclear Proteins (Protein, Nuclear)IBA
10/2020 - 07/2012
3Janus Kinase 3IBA
01/2019 - 09/2009
3VimentinIBA
05/2018 - 01/2012
3Proteasome Endopeptidase Complex (Proteasome)IBA
06/2017 - 09/2013
2MidkineIBA
03/2024 - 01/2022
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
02/2024 - 06/2021

Therapy/Procedure

33Therapeutics
01/2024 - 04/2002
14Transplantation
01/2023 - 01/2004
13Drug Therapy (Chemotherapy)
08/2023 - 01/2010
8Osteotomy
01/2024 - 09/2013
7Activities of Daily Living (ADL)
03/2024 - 12/2017
7Immunotherapy
01/2024 - 08/2015
5Arthroplasty
03/2024 - 01/2022
4Heavy Ion Radiotherapy
04/2023 - 01/2017
4Decompression
11/2016 - 04/2012
3Operative Surgical Procedures
12/2023 - 10/2021
3Cell Transplantation
12/2023 - 01/2004
3Intraperitoneal Injections
11/2023 - 09/2009
3Radiotherapy
12/2022 - 01/2017
3Highly Active Antiretroviral Therapy (HAART)
08/2019 - 03/2010